Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

U. Platzbecker, P. Fenaux, L. Adès, A. Giagounidis, V. Santini, A. A. van de Loosdrecht, D. Bowen, T. de Witte, G. Garcia-Manero, E. Hellström-Lindberg, U. Germing, R. Stauder, L. Malcovati, Mikkael A. Sekeres, David P. Steensma, S. Gloaguen

Blood (2019) 133 (10): 1020–1030.

https://doi.org/10.1182/blood-2018-06-857102

Published: 2019

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J. Hutton, MD, Michael K Racke, MD, Uday R. Popat, M.D., Steven M. Devine, MD, George E. Georges, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Meagan Spychala, Noha Lim, PhD, Sachin Malhotra, PhD, Deborah Phippard, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2012) 120 (21): 962.

https://doi.org/10.1182/blood.V120.21.962.962

Published: 2012

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J Hutton, MD, Michael K Racke, MD, Uday R Popat, MD, Steven M. Devine, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Lisa Wruck, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2011) 118 (21): 3075.

https://doi.org/10.1182/blood.V118.21.3075.3075

Published: 2011

Journal Articles

Sigma 2-Agonist CB-64D Induces Apoptosis in Non Hodgkin’s Lymphoma Cells: Association with Decreased Akt Expression.

Chiara Dell’Agnola, MD, Wojciech Wojciechowski, PhD, Shannon Marshall, Natalia E. Lopez, DDS, Huifen Li, PhD, Wayne D. Bowen, PhD, Igor J. Espinoza-Delgado, MD

Blood (2004) 104 (11): 4619.

https://doi.org/10.1182/blood.V104.11.4619.4619

Published: 2004

Journal Articles

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

Blood (2003) 102 (7): 2364–2372.

https://doi.org/10.1182/blood-2002-12-3908

Published: 2003

Journal Articles

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

P Fenaux, MC Le Deley, S Castaigne, E Archimbaud, C Chomienne, H Link, A Guerci, M Duarte, MT Daniel, D Bowen

Blood (1993) 82 (11): 3241–3249.

https://doi.org/10.1182/blood.V82.11.3241.3241

Published: 1993

Journal Articles

Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies

A Janowska-Wieczorek, AR Belch, A Jacobs, D Bowen, RA Padua, E Paietta, ER Stanley

Blood (1991) 77 (8): 1796–1803.

https://doi.org/10.1182/blood.V77.8.1796.1796

Published: 1991

Journal Articles

Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene

IR Peake, D Bowen, P Bignell, MB Liddell, JE Sadler, G Standen, AL Bloom

Blood (1990) 76 (3): 555–561.

https://doi.org/10.1182/blood.V76.3.555.555

Published: 1990

NARROW

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Sigma 2-Agonist CB-64D Induces Apoptosis in Non Hodgkin’s Lymphoma Cells: Association with Decreased Akt Expression.

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies

Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only